Latest Breaking News On - President juan - Page 1 : vimarsana.com

Arcus Biosciences, Inc (NYSE:RCUS) Receives $41 25 Average Price Target from Analysts

Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight brokerages that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target […]

United statesJuanc jaenJennifer jarrettDecheng capitalDimensional fund advisorsArcus biosciences incVanguard group incSecurities exchange commissionArcus biosciencesGet free reportBiosciences stock downExchange commissionPresident juanFund advisorsGet freeArcus biosciences daily

Arcus Biosciences, Inc Forecasted to Post Q2 2024 Earnings of ($0 88) Per Share (NYSE:RCUS)

Arcus Biosciences, Inc Forecasted to Post Q2 2024 Earnings of ($0 88) Per Share (NYSE:RCUS)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesJennifer jarrettJuanc jaenSecurities exchange commissionAlps advisors incArcus biosciences incAllspring global investments holdingsProshare advisorsArcus biosciencesFree reportArcus bioscienceGet free reportBiosciences trading downShare advisorsGlobal investments holdingsArizona state retirement system

Brokers Set Expectations for Arcus Biosciences, Inc s Q1 2025 Earnings (NYSE:RCUS)

Brokers Set Expectations for Arcus Biosciences, Inc s Q1 2025 Earnings (NYSE:RCUS)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesJuanc jaenJennifer jarrettArcus biosciences incArcus biosciences company profileSecurities exchange commissionCitigroup incVanguard group incArcus biosciencesFree reportArcus bioscienceGet free reportEight capitalDark forest capital managementExchange commissionPresident juan

Equities Analysts Offer Predictions for Arcus Biosciences, Inc s Q1 2025 Earnings (NYSE:RCUS)

Equities Analysts Offer Predictions for Arcus Biosciences, Inc s Q1 2025 Earnings (NYSE:RCUS)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesJennifer jarrettJuanc jaenHeadlands technologiesArcus biosciences incSpartan fund management incArcus biosciences company profileSecurities exchange commissionArcus biosciencesFree reportArcus bioscienceGet free reportEmployees retirement systemFund managementExchange commissionPresident juan

Arcus Biosciences (NYSE:RCUS) Announces Earnings Results, Beats Estimates By $0 92 EPS

Arcus Biosciences (NYSE:RCUS) Announces Earnings Results, Beats Estimates By $0 92 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesJennifer jarrettJuanc jaenArcus biosciences company profileArcus biosciences incArcus biosciencesGet free reportPresident juanArcus biosciences daily